Needham analyst Gil Blum downgrades Aeglea BioTherapeutics (NASDAQ:AGLE) from Buy to Hold.
Wyndham Hotels & Resorts Q3 Adj. EPS $1.16 Beats $0.91 Estimate, Sales $463.00M Beat $462.78M Estimate
Wyndham Hotels & Resorts (NYSE:WH) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $0.91 by 27.47 percent. This is a 222.22 percent increase over earnings of $0.36 per share
